ZURA (Zura Bio Limited) Short-Term Debt to Capital
The price action of Zura Bio Limited (ZURA) securities on the GURU.Markets platform demonstrates the 0.00 indicator. Zura Bio Limited (ZURA) focuses on antibody development, currently generating no revenue and relying on external investments. The business is building a closed drug development environment, securing proprietary rights to therapy methods. Asset value remains independent of economic cycles and is determined exclusively by the outcomes of medical trials.
Analytical breakdowns for Zura Bio Limited
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Zura Bio
The ratio is calculated as the proportion of liabilities with a maturity of up to one year to total equity. This metric determines the business's degree of dependence on short-term borrowing and the risk of insolvency. For Zura Bio Limited (ZURA), debt control is critical when financing the environmental modernization of laboratories and implementing filtration systems. Analysis of the short-term debt-to-equity chart allows for an assessment of the company's resilience to financial shocks.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|Current Liabilities to Equity SEPN|PVLA (Pieris Pharmaceuticals) - Short-Term Debt to Equity Ratio|savarapharma.com (SVRA) - Short-Term Debt to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|ANAB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ATXS|Short-Term Debt to Capital enGene Corp (ENGN)|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital JBIO|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|KYTX: Short-Term Debt to Equity|TLSA: Short-Term Debt to Capital|CABA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ventyx Biosciences|Current Liabilities to Capital theratech.com THTX|Short-Term Debt to Equity Ratio AVTX (Avalo Therapeutics)|ELDN (Eledon Pharmaceuticals Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Agenus Inc AGEN|Climb Bio, Inc - Short-Term Debt to Equity|aTyr Pharma, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adagene ADAG|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Shattuck Labs|EQ (Equillium Inc) - Short-Term Debt to Capital|Connect Pharma (CNTB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio IMUX (Immunic, Inc.)|Short-Term Loans to Capital Ratio ATRA|Short-Term Debt to Capital IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Current Liabilities to Capital|Adicet - Short-Term Debt to Capital|CELU (Celularity Inc.) - Short-Term Debt to Capital Ratio|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|Current Liabilities to Equity BRNS (barinthusbio.com)|Short-Term Debt to Equity Ratio KZR|Short-Term Debt to Capital SAB Biotherapeutics Inc.|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|ENLV (enlivex.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital QTTB (Q32 Bio)|Short-Term Debt to Capital geovax.com GOVX|EDSA - Short-Term Debt to Equity|Current Liabilities to Equity IBIO|CARM: Short-Term Debt to Capital|XTL Bio - Ratio of Short-Term Indebtedness to Capital|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital HCW Biologics Inc|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI - Short-Term Debt to Equity Ratio|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity Ratio|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|SCNI (Scinai) - Short-Term Debt to Capital|CalciMedica Corp (CALI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS - Short-Term Debt to Equity Ratio|ITOS: Short-Term Debt to Equity Ratio|OCEA - Short-Term Debt to Capital|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio THRD